New bone formation by allogeneic mesenchymal stem cell transplantation in a patient with perinatal hypophosphatasia.

[1]  Robert H. Anderson,et al.  Tetralogy of Fallot , 2009, Orphanet journal of rare diseases.

[2]  P. Conte,et al.  Donor cell-derived osteopoiesis originates from a self-renewing stem cell with a limited regenerative contribution after transplantation. , 2008, Blood.

[3]  R. Terkeltaub,et al.  Enzyme Replacement Therapy for Murine Hypophosphatasia , 2007, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[4]  A. Nauta,et al.  Immunomodulatory properties of mesenchymal stromal cells. , 2007, Blood.

[5]  R. Cahill,et al.  Infantile hypophosphatasia: transplantation therapy trial using bone fragments and cultured osteoblasts. , 2007, The Journal of clinical endocrinology and metabolism.

[6]  Masahiro Ito,et al.  Aberrant interchain disulfide bridge of tissue‐nonspecific alkaline phosphatase with an Arg433→Cys substitution associated with severe hypophosphatasia , 2006, The FEBS journal.

[7]  Meir Liebergall,et al.  Osteogenic Differentiation of Noncultured Immunoisolated Bone Marrow‐Derived CD105+ Cells , 2006, Stem cells.

[8]  S. Khosla,et al.  Circulating Cells with Osteogenic Potential , 2006, Annals of the New York Academy of Sciences.

[9]  H. Ohgushi,et al.  Tissue engineered ceramic artificial joint--ex vivo osteogenic differentiation of patient mesenchymal cells on total ankle joints for treatment of osteoarthritis. , 2005, Biomaterials.

[10]  A. Hinke,et al.  Cyclosporine A and Mycophenolate Mofetil vs Cyclosporine A and Methotrexate for graft-versus-host disease prophylaxis after stem cell transplantation from HLA-identical siblings , 2005, Bone Marrow Transplantation.

[11]  N. El-Badri,et al.  Replacement of recipient stromal/mesenchymal cells after bone marrow transplantation using bone fragments and cultured osteoblast-like cells. , 2004, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[12]  Hajime Ohgushi,et al.  Bone regeneration by grafting of cultured human bone. , 2004, Tissue engineering.

[13]  H. Ohgushi,et al.  Clinical application of marrow mesenchymal stem cells for hard tissue repair. , 2004, Yonsei medical journal.

[14]  K. Koyama,et al.  Severe perinatal hypophosphatasia due to homozygous deletion of T at nucleotide 1559 in the tissue nonspecific alkaline phosphatase gene , 2003, Prenatal diagnosis.

[15]  J. Kurtzberg,et al.  Marrow Cell Transplantation for Infantile Hypophosphatasia , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[16]  R. Rutherford,et al.  Bone morphogenetic protein-transduced human fibroblasts convert to osteoblasts and form bone in vivo. , 2002, Tissue engineering.

[17]  L. Muul,et al.  Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[18]  A. Morris,et al.  Infantile hypophosphatasia: disappointing results of treatment , 2000, Acta paediatrica.

[19]  Darwin J. Prockop,et al.  Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta , 1999, Nature Medicine.

[20]  C. Langman,et al.  Infantile hypophosphatasia: treatment options to control hypercalcemia, hypercalciuria, and chronic bone demineralization. , 1997, The Journal of pediatrics.

[21]  Denise,et al.  Hypophosphatasia: levels of bone alkaline phosphatase immunoreactivity in serum reflect disease severity. , 1996, The Journal of clinical endocrinology and metabolism.

[22]  P. Henthorn,et al.  Different missense mutations at the tissue-nonspecific alkaline phosphatase gene locus in autosomal recessively inherited forms of mild and severe hypophosphatasia. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[23]  Arnold I. Caplan,et al.  Mesenchymal Stem Cells , 1991, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[24]  V. Goldberg,et al.  The origin of bone formed in composite grafts of porous calcium phosphate ceramic loaded with marrow cells. , 1991, Clinical orthopaedics and related research.

[25]  H. Harris,et al.  A missense mutation in the human liver/bone/kidney alkaline phosphatase gene causing a lethal form of hypophosphatasia. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[26]  M. Yamada,et al.  A human Y-chromosome specific repeated DNA family (DYZ1) consists of a tandem array of pentanucleotides. , 1986, Nucleic acids research.

[27]  W. Mcalister,et al.  Enzyme replacement therapy for infantile hypophosphatasia attempted by intravenous infusions of alkaline phosphatase-rich Paget plasma: results in three additional patients. , 1984, The Journal of pediatrics.

[28]  D. Fraser,et al.  Treatment of hypophosphatasia with cortisone. , 1956, Lancet.

[29]  D. Rimoin,et al.  Perinatal lethal hypophosphatasia; Clinical, radiologic and morphologic findings , 2005, Pediatric Radiology.

[30]  A I Caplan,et al.  Stem cell technology and bioceramics: from cell to gene engineering. , 1999, Journal of biomedical materials research.

[31]  H. Ohgushi,et al.  Primary Bone Formation in Porous Hydroxyapatite Ceramic: A Light and Scanning Electron Microscopic Study , 1991 .